U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617532) titled 'Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma' on May 25.
Brief Summary: This study aims to evaluate the safety and efficacy of DNN.31.19.026 compared with Cosopt(R) for the treatment of ocular hypertension or primary open-angle glaucoma.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Ocular Hypertension
Primary Open Angle Glaucoma
Intervention:
DRUG: Product DNN.31.19.026
One drop in the affected eye twice daily
DRUG: COSOPT(R)
One drop in the affected eye twice daily
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Publ...